DNA vs. QSI
DNA (Ginkgo Bioworks Holdings, Inc.) and QSI (Quantum-Si incorporated) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, DNA returned -53.32%/yr vs -39.66%/yr for QSI. A 0.50 correlation means they provide meaningful diversification when combined.
Performance
DNA vs. QSI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DNA achieves a 6.62% return, which is significantly higher than QSI's -20.00% return.
DNA
- 1D
- -1.99%
- 1M
- 5.35%
- YTD
- 6.62%
- 6M
- 1.03%
- 1Y
- 3.87%
- 3Y*
- -49.30%
- 5Y*
- -53.32%
- 10Y*
- —
QSI
- 1D
- -4.47%
- 1M
- -16.98%
- YTD
- -20.00%
- 6M
- -28.46%
- 1Y
- -46.67%
- 3Y*
- -17.20%
- 5Y*
- -39.66%
- 10Y*
- —
DNA vs. QSI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DNA Ginkgo Bioworks Holdings, Inc. | 6.62% | -15.38% | -85.47% | 0.00% | -79.66% | -16.06% |
QSI Quantum-Si incorporated | -20.00% | -59.26% | 34.33% | 9.84% | -76.75% | -25.40% |
Correlation
The correlation between DNA and QSI is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jun 10, 2021 | 0.50 |
The correlation between DNA and QSI has been stable across timeframes, ranging from 0.50 to 0.55 - a consistent structural relationship.
Fundamentals
DNA:
$527.73M
QSI:
$190.50M
DNA:
-$5.40
QSI:
-$0.51
DNA:
4.10
QSI:
95.85
DNA:
1.19
QSI:
0.95
DNA:
$121.84M
QSI:
$1.85M
DNA:
$99.27M
QSI:
-$3.71M
DNA:
-$218.90M
QSI:
-$104.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DNA vs. QSI — Risk / Return Rank
DNA
QSI
DNA vs. QSI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Quantum-Si incorporated (QSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DNA | QSI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.54 | ||
| Sortino ratioReturn per unit of downside risk | +1.13 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 0.96 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.06 | -0.64 | +0.70 |
| Martin ratioReturn relative to average drawdown | 0.10 | -0.93 | +1.02 |
Loading charts...
Drawdowns
DNA vs. QSI - Drawdown Comparison
The maximum DNA drawdown since its inception was -99.10%, roughly equal to the maximum QSI drawdown of -95.33%. Use the drawdown chart below to compare losses from any high point for DNA and QSI.
Loading charts...
Drawdown Indicators
| DNA | QSI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.10% | -95.33% | -3.77% |
Max Drawdown (1Y)Largest decline over 1 year | -66.05% | -72.95% | +6.90% |
Max Drawdown (3Y)Largest decline over 3 years | -94.72% | -83.73% | -10.99% |
Max Drawdown (5Y)Largest decline over 5 years | -99.10% | -95.33% | -3.77% |
Current DrawdownCurrent decline from peak | -98.52% | -93.51% | -5.01% |
Average DrawdownAverage peak-to-trough decline | -79.96% | -79.33% | -0.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.73% | 50.38% | -10.65% |
Volatility
DNA vs. QSI - Volatility Comparison
The current volatility for Ginkgo Bioworks Holdings, Inc. (DNA) is 19.57%, while Quantum-Si incorporated (QSI) has a volatility of 29.41%. This indicates that DNA experiences smaller price fluctuations and is considered to be less risky than QSI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DNA | QSI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.57% | 29.41% | -9.84% |
Volatility (6M)Calculated over the trailing 6-month period | 70.77% | 62.04% | +8.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.62% | 94.15% | +3.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 97.96% | 125.29% | -27.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.20% | 125.20% | -29.00% |
Dividends
DNA vs. QSI - Dividend Comparison
Neither DNA nor QSI has paid dividends to shareholders.
Financials
DNA vs. QSI - Financials Comparison
This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and Quantum-Si incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DNA and QSI have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QSI has higher volatility (29.41%) compared to DNA (19.57%). In terms of maximum drawdown, DNA dropped -99.10% vs QSI's -95.33%.
DNA currently has the higher Sharpe Ratio (0.04 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DNA and QSI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer